Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...